950220.KQ
NeoImmuneTech, Inc.
KOE · Healthcare · Biotechnology · US
KRW 1,984.00
+2.96%Margins
Gross margin
99.7%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-53.9%
Return on equity
-38.9%
Return on assets
-36.0%
Return on invested capital
0.00x
Asset turnover
-KRW 24.3B
Cash from operations
KRW 307
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025